{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:42:36Z","timestamp":1765374156691,"version":"3.46.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011500","name":"Abigail Wexner Research Institute at Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.transci.2025.104253","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:39:51Z","timestamp":1757349591000},"page":"104253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of anticoagulant used for peripheral blood collection on NK cell yield, function, and proliferation"],"prefix":"10.1016","volume":"64","author":[{"given":"Catherine A.","family":"Cash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6693-5392","authenticated-orcid":false,"given":"Dean A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2025.104253_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.transci.2025.104253_bib2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor t cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2025.104253_bib3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) b cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2025.104253_bib4","article-title":"Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV","volume":"2","author":"Naeimi Kararoudi","year":"2022","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.transci.2025.104253_bib5","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood.2020006200","article-title":"CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity","volume":"136","author":"Naeimi Kararoudi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.transci.2025.104253_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100032","article-title":"CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies","author":"Troy","year":"2024","journal-title":"Blood Neoplasia"},{"key":"10.1016\/j.transci.2025.104253_bib7","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood-2014-04-569061","article-title":"Antibody fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells","volume":"124","author":"Romain","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.transci.2025.104253_bib8","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1078-0432.CCR-12-1243","article-title":"Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy","volume":"19","author":"Liu","year":"2013","journal-title":"Clinical Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.transci.2025.104253_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27783","article-title":"Expression of carcinoma, apoptosis, and cell-death-related genes are determinants for sensitivity of pediatric cancer cell lines to lysis by natural killer cells","volume":"66","author":"Ray","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2025.104253_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.transci.2025.104253_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2016.08.007","article-title":"Natural killer cells in malignant hematology: a primer for the non-immunologist","volume":"31","author":"Kannan","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2025.104253_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/imr.12793","article-title":"Cellular therapy: adoptive immunotherapy with expanded natural killer cells","volume":"290","author":"Lee","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.transci.2025.104253_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jcyt.2025.04.064","article-title":"Dark NKnight rising: a current perspective on NK cell and CAR-NK cell therapy","volume":"27","author":"Caporale","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.transci.2025.104253_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/bjh.17751","article-title":"Adoptive immunotherapy with double-bright (CD56(bright) \/CD16(bright)) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study","volume":"195","author":"Silla","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2025.104253_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41375-021-01349-4","article-title":"Decrease post-transplant relapse using donor-derived expanded NK-cells","volume":"36","author":"Ciurea","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.transci.2025.104253_bib16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.27281","article-title":"Results of a phase I trial with haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML","volume":"99","author":"Ciurea","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2025.104253_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/14653249.2010.506507","article-title":"Shipping of therapeutic somatic cell products","volume":"13","author":"Whiteside","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.transci.2025.104253_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CDLI.5.5.695-702.1998","article-title":"Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes","volume":"5","author":"Shalekoff","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.transci.2025.104253_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcyt.2022.05.003","article-title":"Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing","volume":"24","author":"Qayed","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.transci.2025.104253_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.1989.tb22496.x","article-title":"Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate","volume":"556","author":"Ofosu","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.transci.2025.104253_bib21","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/j.1538-7836.2007.02710.x","article-title":"Citrate anticoagulation and the dynamics of thrombin generation","volume":"5","author":"Mann","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2025.104253_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/clinchem\/34.1.110","article-title":"Effect of two anticoagulants on leukocyte yield and function, and on lysosomal enzyme activity","volume":"34","author":"Branum","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.transci.2025.104253_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","article-title":"Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials","volume":"322","author":"Bull","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.transci.2025.104253_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/cdli.3.3.260-264.1996","article-title":"Effects of anticoagulant, serum, and temperature on the natural killer activity of human peripheral blood mononuclear cells stored overnight","volume":"3","author":"Son","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.transci.2025.104253_bib25","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.1013285108","article-title":"ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis","volume":"108","author":"Maul-Pavicic","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2025.104253_bib26","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1242\/jcs.02442","article-title":"Cold-induced coalescence of T-cell plasma membrane microdomains activates signalling pathways","volume":"118","author":"Magee","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.transci.2025.104253_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.coi.2008.04.004","article-title":"Calcium signaling in lymphocytes","volume":"20","author":"Oh-hora","year":"2008","journal-title":"Curr Opin Immunol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:32:59Z","timestamp":1765369979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050225001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1473050225001910"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2025.104253","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of anticoagulant used for peripheral blood collection on NK cell yield, function, and proliferation","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2025.104253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104253"}}